Russell Esterline
AstraZeneca
11
0
11
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (11)
Showing 10 of 11 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Dr. Prashkrah Deedwania
Institute for Medical consultation, USA
Shared therapeutic areas:
Worked with same sponsors:
Steve Haffner, MD
San Antonio, USA
Shared therapeutic areas:
Worked with same sponsors:
Keith Ferdinand
Heartbeats Life Centre, New Orleans, USA
Shared therapeutic areas:
Worked with same sponsors:
Tom Hatsukami
University of Washington, USA
Shared therapeutic areas:
Worked with same sponsors:
Michael Cressman, DO
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Joel Raichlen
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Alex Gold, MD
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Eleanor Miller, MD
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Prof. Anton Stalenhoef
University Medical Centre, The Netherlands
Shared therapeutic areas:
Worked with same sponsors:
Evan Stein
Metabolic & Athersclerotic research centre, Cincinatti, USA
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (11)
Showing 11 of 11 trials
Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)
Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)
Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR)
Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)
Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic Subjects
Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia
IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin
COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects
STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges
48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease
All 11 trials loaded